The US Food and Drug Administration approved Donanemab, also called Kisunla. Tuesday's decision put the monoclonal antibody ...
Called Donanemab, this treatment from Eli Lilly will be sold under its brand name, Kisunla, and works as an intravenous ...
The latest drug is showing promising results for adults with early Alzheimer's symptoms, mild cognitive impairment (MCI), and ...
It's not a cure-- but it is a step in the right direction.This month-- a new medication for alzheimer's, called 'kinsul'a, ...
The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer's disease. Kisunla is an IV ...
The Food and Drug Administration (FDA) recently approved a new drug from Eli Lilly to treat Alzheimer’s disease. Called ...
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline ...
The new drug, Kisunla, has the potential to be a blockbuster for the company and generate billions in revenue. But despite ...
Learn about the benefits of Kisunla, the newly approved Alzheimer's drug that can modestly slow disease progression in the ...
THANK YOU SO MUCH FOR YOUR TIME AND FOR SHARING MORE ABOUT THIS WITH US, BECAUSE EVERY ONE OF US HAS IMPACTED SOMEBODY WE ...
Lilly argues that Kisunla could be less costly to payers than rivals. It's the only FDA-approved Alzheimer's disease drug ...
The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.